Be Ready for the New Oral GLP-1 Agonist Orforglipron You’ll get questions about orforglipron (Foundayo), the second ORAL GLP-1 receptor agonist approved for adults with overweight or obesity... Resources Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart Chart: Comparison of Weight Loss Products Chart: Drug Interactions: Cytochrome P450 (CYP), P-glycoprotein, and More
Use Evidence to Clear up Questions About Gabapentin Patients are asking more questions about gabapentin claims heard from social media, family and friends, etc...
New Cholesterol Guidelines: Screening, Risk, and Targets Big changes in cholesterol guidelines will spark conversations about managing patients withOUT atherosclerotic cardiovascular disease (ASCVD)...
Brush Up on Non-Opioid Pain Medications You play a crucial role in helping patients manage pain with non-opioid medications...
